Prevalence of Epstein-barr Virus (EBV) among Patients with Oral Squamous Cell Carcinoma from Ahvaz, Iran: A Case-Control Study

References
1. Metgud R, Astekar M, Verma M, Sharma AJOr.
Role of viruses in oral squamous cell carcinoma.
2012;6(2).
2. Zeng X-T, Deng A-P, Li C, Xia L-Y, Niu Y-M,
Leng W-DJPo. Periodontal disease and risk of head and
neck cancer: a meta-analysis of observational studies.
2013;8(10):e79017.
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E,
Forman DJCacjfc. Global cancer statistics.
2011;61(2):69-90.
4. Mirzaei H, Goudarzi H, Eslami G, Faghihloo
EJJoCP. Role of viruses in gastrointestinal cancer.
2018;233(5):4000-14.
5. Bhurgri Y, Rahim A, Bhutto K, Bhurgri A, Pinjani
P, Usman A, et al. Incidence of carcinoma of the oral
cavity in Karachi-District South. 1998;48:321-4.
6. Sankaranarayanan RJOs, oral medicine, oral
pathology. Oral cancer in India: an epidemiologic and
clinical review. 1990;69(3):325-30.
7. Petersen PEJCD, epidemiology o. The World Oral
Health Report 2003: continuous improvement of oral
health in the 21st century–the approach of the WHO
Global Oral Health Programme. 2003;31:3-24.
8. Ghafari R, Naderi NJ, Razavi
AEJJoRiMSTOJoIUoMS. A retrospective institutional
study of histopathologic pattern of Oral Squamous Cell
Carcinoma (OSCC) in Tehran, Iran during 2006-2015.
2019;24.
9. Delavarian Z, Pakfetrat A, Falaki F, Pazouki M,
Pazouki NJJAS. The role of viruses in oral squamous cell
carcinoma in young patients in Khorasan (Northeast of
Iran). 2010;10(11):981-5.
10. Henle G, Henle W, Diehl VJPotNAoSotUSoA.
Relation of Burkitt's tumor-associated herpes-ytpe virus
to infectious mononucleosis. 1968;59(1):94.
11. Mirzaei H, Faghihloo EJRimv. Viruses as key
modulators of the TGF‐β pathway; a double‐edged sword
involved in cancer. 2018;28(2):e1967.
12. Tabibzadeh A, Niya MHK, Esghaei M, BokharaeiSalim F, Ataei-Pirkooh A, Kiani SJ, et al. Molecular
epidemiology of epstein-barr virus (ebv) in patients with
hematologic malignancies. 2020;21(3):693.
13. Dhanuthai K, Rojanawatsirivej S, Thosaporn W,
Kintarak S, Subarnbhesaj A, Darling M, et al. Oral
cancer: A multicenter study. 2018;23(1):e23.
14. Orbak R, Bayraktar C, Kavrut F, Gündogdu
1502 Jalilian et al / Archives of Razi Institute, Vol. 78, No. 5 (2023) 1495-1502
CJOOE. Poor oral hygiene and dental trauma as the
precipitating factors of squamous cell carcinoma.
2005;41(6):109-13.
15. Kobayashi I, Shima K, Saito I, Kiyoshima T,
Matsuo K, Ozeki S, et al. Prevalence of Epstein–Barr
virus in oral squamous cell carcinoma. 1999;189(1):34-9.
16. Shimakage M, Horii K, Tempaku A, Kakudo K,
Shirasaka T, Sasagawa TJHp. Association of Epstein-Barr
virus with oral cancers. 2002;33(6):608-14.
17. Sand LP, Jalouli J, Larsson P-A, Hirsch J-MJOS,
Oral Medicine, Oral Pathology, Oral Radiology,,
Endodontology. Prevalence of Epstein-Barr virus in oral
squamous cell carcinoma, oral lichen planus, and normal
oral mucosa. 2002;93(5):586-92.
18. Gonzalez‐Moles M, Gutierrez J, Rodriguez M,
Ruiz‐Avila I, Rodriguez‐Archilla AJTL. Epstein‐Barr
virus latent membrane protein‐1 (LMP‐1) expression in
oral squamous cell carcinoma. 2002;112(3):482-7.
19. D'Costa J, Saranath D, Sanghvi V, Mehta
ARJJoop, medicine. Epstein‐Barr virus in
tobacco‐induced oral cancers and oral lesions in patients
from India. 1998;27(2):78-82.
20. Prathyusha MM, Kattappagari KK, Chowdary D,
Shekar PC, Alivelu D, Reddy BVRJJoDNUoHS. A study
on association of epstein barr virus in oral squamous cell
carcinoma using polymerase chain reaction technique.
2019;8(4):233.
21. Van Rensburg E, Engelbrecht S, Van Heerden W,
Raubenheimer E, Schoub BJIv. Detection of EBV DNA
in oral squamous cell carcinomas in a black African
population sample. 1995;9(3):199-202.
22. Van Heerden W, Van Rensburg E, Engelbrecht S,
Raubenheimer EJAr. Prevalence of EBV in oral
squamous cell carcinomas in young patients.
1995;15(5B):2335-9.
23. Horiuchi K, Mishima K, Ichijima K, Sugimura M,
Ishida T, Kirita TJOS, Oral Medicine, Oral Pathology,
Oral Radiology,, et al. Epstein-Barr virus in the
proliferative diseases of squamous epithelium in the oral
cavity. 1995;79(1):57-63.
24. Cruz I, Van den Brule A, Steenbergen R, Snijders
P, Meijer C, Walboomers J, et al. Prevalence of Epstein—
Barr virus in oral squamous cell carcinomas,
premalignant lesions and normal mucosa—a study using
the polymerase chain reaction. 1997;33(3):182-8.
25. Tsang NM, Chang KP, Lin SY, Hao SP, Tseng
CK, Kuo Tt, et al. Detection of Epstein‐Barr Virus–
Derived Latent Membrane Protein‐1 Gene in Various
Head and Neck Cancers: Is It Specific for
Nasopharyngeal Carcinoma? 2003;113(6):1050-4.
26. Kis A, Fehér E, Gáll T, Tar I, Boda R, Tóth ED, et
al. Epstein–Barr virus prevalence in oral squamous cell
cancer and in potentially malignant oral disorders in an
eastern Hungarian population. 2009;117(5):536-40.
27. Iamaroon A, Khemaleelakul U, Pongsiriwet S,
Pintong JJJoop, medicine. Co‐expression of p53 and Ki67
and lack of EBV expression in oral squamous cell
carcinoma. 2004;33(1):30-6.
28. Wilms T, Khan G, Coates PJ, Sgaramella N,
Fåhraeus R, Hassani A, et al. No evidence for the
presence of Epstein-Barr virus in squamous cell
carcinoma of the mobile tongue. 2017;12(9):e0184201.
29. Zebardast A, Yahyapour Y, Majidi MS, Chehrazi
M, Sadeghi FJBOH. Detection of Epstein-Barr virus
encoded small RNA genes in oral squamous cell
carcinoma and non-cancerous oral cavity samples.
2021;21(1):1-8.
30. Rickinson AB, Young LS, Rowe MJJov. Influence
of the Epstein-Barr virus nuclear antigen EBNA 2 on the
growth phenotype of virus-transformed B cells.
1987;61(5):1310-7.
31. Shahani T, Makvandi M, Samarbafzadeh A,
Teimoori A, Ranjbar N, Nikakhlagh S, et al. Frequency of
Epstein Barr virus type 1 among nasopharyngeal
carcinomas in Iranian patients. 2017;18(2):327.